间歇性禁食减轻牙炎症:一项三臂临床试验
C L Pappe1, J Maetschker1, S Dujardin2
1Department of Periodontology, Oral Medicine and Oral Surgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, and Humboldt-Universität zu Berlin, Berlin, Germany.
Journal of clinical periodontology
|March 10, 2025
概括
宗教巴哈教的宗教巴哈教.
科学领域:
- 牙周病学 牙周病学
- 代谢健康 代谢健康
- 营养科学 营养科学
背景情况:
- 实验性牙炎是一种常见的口腔健康问题.
- 禁食协议,如巴哈伊干禁食 (BF) 和16:8时间限制饮食 (TRE),越来越多地研究其对健康的影响.
- 了解饮食,禁食和口腔健康之间的相互作用至关重要.
研究的目的:
- 为了比较BF和TRE与对照组 (CG) 在实验诱导的牙炎期间对牙周健康的影响.
- 评估这些饮食干预措施对关键代谢和炎症标志物的影响.
主要方法:
- 这项研究招募了66名健康参与者.
- 参与者接受了为期9天的不进行口腔卫生以诱发牙炎,随后进行了为期19天的观察期,恢复了卫生,并分配了饮食方案 (BF,TRE或CG).
- 测量了牙周参数 (探针出血,斑块指数,牙裂液) 和代谢标记 (血压,体重,HbA1c,C反应蛋白).
主要成果:
- 巴哈伊干禁食 (BF) 显示,与对照组 (CG) 和时间限制饮食 (TRE) 相比,探测时出血 (BOP_s) 的增加显著减少.
- 牙裂液 (GCF) 水平在CG中增加,但在BF或TRE组中没有增加.
- 在禁食组 (BF,TRE) 和CG之间观察到BOP和GCF变化的显著差异.
结论:
- 巴哈伊干禁食 (BF) 和16:8时限饮食 (TRE) 均对实验性牙炎和相关代谢参数产生有益影响.
- 禁食干预措施可能会对牙炎的发展产生保护作用.
- 局限性包括随机化问题和BF组的潜在偏见,需要进一步调查.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
291
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
291
Dipeptidyl Peptidase 4 Inhibitors
155
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
155


